首页> 外国专利> PHARMACEUTICAL COMPOSITION INCLUDING MITOTANE FOR ORAL ADMINISTRATION FOR THE TREATMENT OF CORTICOSURRENAL CARCINOMA AND CUSHING SYNDROME

PHARMACEUTICAL COMPOSITION INCLUDING MITOTANE FOR ORAL ADMINISTRATION FOR THE TREATMENT OF CORTICOSURRENAL CARCINOMA AND CUSHING SYNDROME

机译:药物组合物,包括用于口服施用皮质癌和缓冲综合征的口服给药

摘要

The present invention relates to the preparation and use of a novel dry emulsion (ES) containing mitotane and its use for the oral route for the treatment of adrenal cortical carcinoma, congenital adrenal hyperplasia and Cushing's syndrome. Figure for the abstract: Fig 2
机译:本发明涉及含有测定型胶质烷的新型干乳液的制备和用途及其用于治疗肾上腺皮质癌,先天性肾上腺增生和缓冲综合征的口腔途径。摘要的图:图2

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号